{"version":"1.0","provider_name":"Faus Moliner","provider_url":"https:\/\/faus-moliner.com\/ca\/","author_name":"Faus Moliner","author_url":"https:\/\/faus-moliner.com\/ca\/author\/moon\/","title":"Innovaci\u00f3n farmac\u00e9utica: diferentes enfoques, mismo objetivo - Faus Moliner","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"nUI9Vav8Ct\"><a href=\"https:\/\/faus-moliner.com\/ca\/innovacion-farmaceutica-diferentes-enfoques-mismo-objetivo\/\">Innovaci\u00f3n farmac\u00e9utica: diferentes enfoques, mismo objetivo<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/faus-moliner.com\/ca\/innovacion-farmaceutica-diferentes-enfoques-mismo-objetivo\/embed\/#?secret=nUI9Vav8Ct\" width=\"600\" height=\"338\" title=\"&#8220;Innovaci\u00f3n farmac\u00e9utica: diferentes enfoques, mismo objetivo&#8221; &#8212; Faus Moliner\" data-secret=\"nUI9Vav8Ct\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/faus-moliner.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"La Administraci\u00f3n de Alimentos y Medicamentos de EEUU (FDA, por sus siglas en ingl\u00e9s) ha anunciado recientemente la creaci\u00f3n de un programa denominado \u201cPrograma de Vales de Prioridad Nacional del Comisionado\u201d (Commissioner\u2019s National Priority Voucher Program). Se trata de una iniciativa que busca acelerar, a trav\u00e9s de un procedimiento \u201cfast-track\u201d, la aprobaci\u00f3n de nuevos medicamentos... M\u00e9s informaci\u00f3"}